Tenet Healthcare/$THC
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Tenet Healthcare
Tenet Healthcare is a Dallas-based healthcare services organization. It operates acute and specialty hospitals (47 as of December 2024) and over 500 ambulatory surgery centers and other outpatient facilities across the US, primarily in the South. Through its Conifer segment, Tenet also provides revenue cycle management solutions.
Ticker
$THC
Sector
Primary listing
NYSE
Employees
86,240
Headquarters
Website
Tenet Healthcare Metrics
BasicAdvanced
$18B
14.01
$14.57
1.52
-
Price and volume
Market cap
$18B
Beta
1.52
52-week high
$217.43
52-week low
$109.82
Average daily volume
1M
Financial strength
Current ratio
1.713
Quick ratio
1.205
Long term debt to equity
150.598
Total debt to equity
151.575
Interest coverage (TTM)
4.45%
Profitability
EBITDA (TTM)
4,710
Gross margin (TTM)
41.04%
Net profit margin (TTM)
6.50%
Operating margin (TTM)
17.49%
Effective tax rate (TTM)
17.27%
Revenue per employee (TTM)
$240,000
Management effectiveness
Return on assets (TTM)
8.26%
Return on equity (TTM)
27.36%
Valuation
Price to earnings (TTM)
14.012
Price to revenue (TTM)
0.902
Price to book
4.47
Price to tangible book (TTM)
-2.11
Price to free cash flow (TTM)
12.522
Free cash flow yield (TTM)
7.99%
Free cash flow per share (TTM)
16.307
Growth
Revenue change (TTM)
-0.64%
Earnings per share change (TTM)
-53.38%
3-year revenue growth (CAGR)
3.07%
10-year revenue growth (CAGR)
1.44%
3-year earnings per share growth (CAGR)
42.07%
10-year earnings per share growth (CAGR)
55.56%
What the Analysts think about Tenet Healthcare
Analyst ratings (Buy, Hold, Sell) for Tenet Healthcare stock.
Bulls say / Bears say
Tenet reported Q1 2025 adjusted EBITDA of $1.163 billion, a 13.6% year-over-year increase, with a 22.3% margin, supported by strong same-hospital admissions growth and disciplined expense management (Tenet Investor Relations).
S&P Global Ratings upgraded Tenet to BB- from B+ on June 23 2025, citing improved credit metrics, a reduced 3.5x leverage ratio, and strong expansion of ambulatory surgery centers, strengthening the company’s financial flexibility (Investing.com).
After its Q3 2025 results, Tenet increased its FY 2025 adjusted EBITDA guidance by $50 million at the midpoint to $4.47–$4.57 billion, reflecting sustained strong operating performance and robust free cash flow generation (Tenet Investor Relations).
Tenet’s net operating revenues in Q1 2025 fell 7.9% year-over-year to $5.223 billion, mainly due to hospital divestitures, underscoring its reliance on asset sales for top-line growth (Tenet Investor Relations).
As of December 31 2024, Tenet had $3.0 billion in cash and cash equivalents set against $13.1 billion in long-term debt, resulting in net debt over $10 billion and a higher leverage risk as interest rates rise (Nasdaq).
On November 3 2025, Tenet completed a $2.25 billion notes offering—including 5.500% first-lien and 6.000% senior notes—raising its average borrowing cost and increasing future interest expenses (Investing.com).
Data summarised monthly by Lightyear AI. Last updated on 6 Nov 2025.
Tenet Healthcare Financial Performance
Revenues and expenses
Tenet Healthcare Earnings Performance
Company profitability
Tenet Healthcare News
AllArticlesVideos
Tenet Announces Upsizing and Pricing of Its $2.25 Billion Private Offerings of Senior Secured Notes and Senior Notes
Business Wire4 days ago
Tenet Reports Strong Third Quarter 2025 Results; Raises 2025 Financial Outlook
Business Wire2 weeks ago
Tenet to Participate in the 2025 Wells Fargo Healthcare Conference
Business Wire2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Tenet Healthcare stock?
Tenet Healthcare (THC) has a market cap of $18B as of November 08, 2025.
What is the P/E ratio for Tenet Healthcare stock?
The price to earnings (P/E) ratio for Tenet Healthcare (THC) stock is 14.01 as of November 08, 2025.
Does Tenet Healthcare stock pay dividends?
No, Tenet Healthcare (THC) stock does not pay dividends to its shareholders as of November 08, 2025.
When is the next Tenet Healthcare dividend payment date?
Tenet Healthcare (THC) stock does not pay dividends to its shareholders.
What is the beta indicator for Tenet Healthcare?
Tenet Healthcare (THC) has a beta rating of 1.52. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.